World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
73374
World Ranking
4627
National Ranking
2512

Overview

C. Warren Olanow is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research focuses primarily on neurological disorders, with an emphasis on Parkinson's disease and related treatments. The scientist has contributed substantially to the fields of Medicine and Neuroscience, with notable work in Neurology, Cellular and Molecular Neuroscience, Cognitive Neuroscience, Molecular Biology, and Psychiatry and Mental Health.

The main topics of their research include:

  • Parkinson's Disease Mechanisms and Treatments
  • Neurological Disorders and Treatments
  • Botulinum Toxin and Related Neurological Disorders
  • Nuclear Receptors and Signaling
  • Autism Spectrum Disorder Research
  • Chronic Myeloid Leukemia Treatments
  • Neuroscience and Neuropharmacology Research

They have authored multiple research papers, some of the recent ones being:

  • "Disease modification and biomarker development in Parkinson disease," 2020, published in Neurology
  • "Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial," 2023, published in The Lancet Neurology
  • "Continuous Dopaminergic Stimulation as a Treatment for Parkinson's Disease: Current Status and Future Opportunities," 2020, published in Movement Disorders
  • "Long-term post-mortem studies following neurturin gene therapy in patients with advanced Parkinson's disease," 2020, published in Brain
  • "Continuous Subcutaneous Levodopa Delivery for Parkinson's Disease: A Randomized Study," 2020, published in Journal of Parkinson s Disease

Their frequent co-authors include:

  • Karl Kieburtz
  • Fabrizio Stocchi
  • Andrew McGarry
  • Werner Poewe
  • Alberto J. Espay

Olanow's research is often published in venues such as Movement Disorders, Neurology, The Lancet Neurology, Journal of Parkinson s Disease, and Brain. The majority of their publications appear in Movement Disorders and Neurology journals.

Best Publications

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

    Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins

  • MDS clinical diagnostic criteria for Parkinson's disease

    Ronald B. Postuma;Daniela Berg;Matthew Stern;Werner Poewe

  • Levodopa and the progression of Parkinson's disease.

    Fahn S;Oakes D;Shoulson I;Kieburtz K

  • Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

    Jeffrey H Kordower;Yaping Chu;Robert A Hauser;Thomas B Freeman

  • A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease†

    C. Warren Olanow;Christopher G. Goetz;Jeffrey H. Kordower;A. Jon Stoessl

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.

    Christopher G. Goetz;Stanley Fahn;Pablo Martinez-Martin;Werner Poewe

  • MDS research criteria for prodromal Parkinson's disease

    Daniela Berg;Ronald B. Postuma;Charles H. Adler;Bastiaan R. Bloem

  • Disease duration and the integrity of the nigrostriatal system in Parkinson’s disease

    Jeffrey H. Kordower;C. Warren Olanow;Hemraj B. Dodiya;Yaping Chu

  • International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease : The NMSQuest study

    Kallol Ray Chaudhuri;Pablo Martinez-Martin;Anthony H.V. Schapira;Fabrizio Stocchi

  • Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force

    Bruno Dubois;David Burn;Christopher Goetz;Dag Aarsland;Dag Aarsland

  • The scientific and clinical basis for the treatment of Parkinson disease (2009)

    C. Warren Olanow;Matthew B. Stern;Kapil Sethi

  • Neuropathological Evidence of Graft Survival and Striatal Reinnervation after the Transplantation of Fetal Mesencephalic Tissue in a Patient with Parkinson's Disease

    J H Kordower;T B Freeman;B J Snow;F J Vingerhoets

  • Pathophysiology of the basal ganglia in Parkinson's disease.

    José A. Obeso;Maria C. Rodriguez-Oroz;Manuel Rodriguez;José L. Lanciego

  • A double-blind, delayed-start trial of rasagiline in Parkinson's disease.

    C. Warren Olanow;Olivier Rascol;Robert Hauser;Paul D. Feigin

  • An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines.

    C. W. Olanow;Ray L. Watts;William C. Koller

  • Altered Proteasomal Function in Sporadic Parkinson's Disease

    Kevin St. P. McNaught;Roger Belizaire;Ole Isacson;Peter Jenner

  • Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial

    William J Marks;Jill L Ostrem;Leonard Verhagen;Philip A Starr

  • Protein Nitration in Parkinson's Disease

    P F Good;A Hsu;P Werner;D P Perl

  • Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease.

    Kevin St. P. McNaught;Daniel P. Perl;Anna-Liisa Brownell;C. Warren Olanow

  • Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.

    William J Marks;Raymond T Bartus;Joao Siffert;Charles S Davis

Frequent Co-Authors

Jose A. Obeso
Jose A. Obeso CEU San Pablo University
Jeffrey H. Kordower
Jeffrey H. Kordower Arizona State University
Anthony E. Lang
Anthony E. Lang University of Toronto
Fabrizio Stocchi
Fabrizio Stocchi San Raffaele University of Rome
Karl Kieburtz
Karl Kieburtz University of Rochester Medical Center
Werner Poewe
Werner Poewe Innsbruck Medical University
Robert A. Hauser
Robert A. Hauser University of South Florida
Christopher G. Goetz
Christopher G. Goetz Rush University Medical Center
Anthony H.V. Schapira
Anthony H.V. Schapira University College London
Matthew B. Stern
Matthew B. Stern University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up multiple education pathways beyond the traditional MD. Online nursing degrees continue to rise in popularity, allowing students to study flexibly while balancing work or family commitments. If you’re comparing programs, it helps to consider cheapest online fnp programs as a fast route to advanced practice, or look at how much does online nursing school cost to better plan your financial investment.

For experienced nurses, completing a bachelor’s degree may be a key step. You can find information on the cheapest rn to bsn online programs to maximize career opportunities affordably. For those interested in research, teaching, or leadership in healthcare, pursuing a phd nursing education online opens the door to high-level roles.

Whether choosing a clinical, academic, or administrative medical path, flexible online options make advancing your career in medicine more accessible than ever.

Best Scientists Citing C. Warren Olanow

Trending Scientists

Recently Published Articles